Nobel Week kicks off for immunotherapy innovator Jim Allison
2 minute read | Published December 06, 2018
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on December 06, 2018
As his first official act of Nobel Week, 2018 Nobel Laureate in Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the bottom of a chair at Bistro Nobel in the Nobel Museum in Stockholm’s Old Town. The chair-signing is part of a traditional museum visit by Nobel winners, and launches the week’s events.
Allison, chair of Immunology at MD Anderson, along with co-winner Tasuku Honjo, M.D., Ph.D., of Kyoto University, discussed their research later in the morning at a news conference.
Allison invented immune checkpoint blockade, a therapeutic approach that treats the immune system, unleashing it to attack cancer. His research led to development of ipilimumab, known commercially as Yervoy, the first drug of its kind. Honjo was instrumental in the later development of a second drug that hits a different target on the surface of cells.
“By stimulating the ability of our immune system to attack tumor cells, this year’s Nobel Prize laureates have established an entirely new principle for cancer therapy,” Thomas Perlmann, secretary of the Nobel Committee for Physiology or Medicine, noted in announcing the award on Oct. 1.
A detailed account of Allison’s and Honjo’s research is available on the Nobel website. On Friday, the two laureates will deliver their Nobel lectures, which will be livestreamed on the Nobel website and on Youtube at 7 a.m. CST.
Traditionally, Nobel Laureates also donate artifacts to the Nobel Museum. Allison presented the museum with the following items:
- A vial representing 9H10, a mouse-model monoclonal antibody developed in his lab in 1995 to block CTLA-4, a protein on T cells that shuts down immune response
- A vial of ipilimumab from Bristol-Myers Squibb that was developed for human use based on Allison’s work
- The first page of a 1996 article in Science that reported the success of anti-CTLA-4 treatment in freeing T cells to attack cancer in mice
- The first page of a 2015 review in Cell that was co-authored by Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology, Allison’s longtime research collaborator and spouse
- A portrait of Allison and Sharma taken by a Dallas photographer
A series of meetings, receptions and dinners unfold over the weekend, culminating in the presentation of the Nobel Prizes in Physiology or Medicine, Physics, Chemistry and Economics by the King of Sweden at 9:30 a.m. CST on Monday, Dec. 10. The award ceremony also will be live-streamed.
